Do We Need Individualized Therapeutic Strategies in High-Risk Patients Treated With Hypothermia?
暂无分享,去创建一个
[1] K. Kern,et al. Therapeutic Hypothermia and Stent Thrombosis: A Nationwide Analysis. , 2016, JACC. Cardiovascular interventions.
[2] G. Schuler,et al. Multivessel versus culprit lesion only percutaneous revascularization plus potential staged revascularization in patients with acute myocardial infarction complicated by cardiogenic shock: Design and rationale of CULPRIT-SHOCK trial. , 2016, American heart journal.
[3] C. Mues,et al. High rates of prasugrel and ticagrelor non-responder in patients treated with therapeutic hypothermia after cardiac arrest. , 2014, Resuscitation.
[4] P. Klepstad,et al. Antiplatelet effect of clopidogrel is reduced in patients treated with therapeutic hypothermia after cardiac arrest. , 2010, Resuscitation.
[5] Françoise Dignat-George,et al. Tailored clopidogrel loading dose according to platelet reactivity monitoring to prevent acute and subacute stent thrombosis. , 2009, The American journal of cardiology.